Members Directory (Top Menu)
OBN’s Corporate Membership of 370-plus organisations includes many R&D companies (therapeutic, medical technology and diagnostics) as well as an extensive range of contract research (CRO) and manufacturing (CMO) organisations, companies in the associated industries and specialists suppliers.
Search for companies by Sector or Subsector, Keyword or use the alphabetical listing. Only details of current OBN Members appear here.
Abingdon Health LimitedAbingdon Health LimitedDevelopment, manufacturing and commercialisation of rapid lateral flow assay and reader systems.
Abingdon Health is a UK based company focused on developing, manufacturing and commercialising rapid and near-patient diagnostic immunoassay testing.
Our initial focus is on developing rapid tests for haematology oncology and specifically B cell dyscrasias. In 2015 we launched Seralite®– FLC Serum, a rapid device for multiple myeloma, which uses lateral flow technology along with our FDA registered and CE marked lateral flow reader, ADxLR5®.
As well as producing our own rapid diagnostic products, our contract services team provide assay development and manufacturing for customers (healthcare, veterinary and food) with validated reagents, or who are looking to transfer existing laboratory based assays to lateral flow.
Accompanying this we offer lateral flow reader OEM solutions using technology taken from ADxLR5®.
Our environmentally controlled manufacturing facility is certified to ISO13485 for the design, development and manufacturing of lateral flow devices and device readers.
Our manufacturing facilities are also GMP compliant, with the FDA, for the design, development and manufacture of lateral flow devices, and device readers for in vitro diagnostic medical use.
Absolute Antibody LtdAbsolute Antibody LtdOur core aim is to provide engineered antibodies for all. This means giving access to the whole R & D community, not just a select few.
Absolute aims to give customers new types of reagents, more reproducible results and cleaner results (through ways to minimise background staining).
Our main services cover: antibody engineering and class switching, antibody expression and hybridoma sequencing.
AbzenaAbzenaAbzena is the new name for the PolyTherics and Antitope group, and provides services to enable the development of better biopharmaceuticals
Abzena is the new name for the PolyTherics group, and is focused on providing proprietary technologies and value-added services to enable the development of better biopharmaceuticals.
Abzena comprises two wholly owned subsidiary businesses – PolyTherics and Antitope – which have established a broad suite of complementary technologies that are designed to improve the chances of successful development of antibodies and proteins with enhanced therapeutic benefits.
PolyTherics specializes in proprietary site-specific conjugation technologies for antibody drug conjugate development and solutions for optimisation of the therapeutic properties of biopharmaceuticals.
Antitope is an industry leader in immunogenicity assessment, protein engineering to create humanized antibodies and deimmunised therapeutic proteins and cell line development for manufacture.
The group has built a global customer base over the past decade, including the top 10 pharma, large and small biotech, and academic groups.
Accentus Medical LtdAccentus Medical LtdDevelopment of advanced surface technologies, coatings and treatments
Address: 528.10 Unit 2, Rutherford Avenue, Harwell, OX11 0DF
Agenda 1 Analytical Services LtdAgenda 1 Analytical Services LtdAgenda1 deliver high quality analytical support to companies across a varied range of industries
Agenda1 deliver high quality analytical support to companies across a varied range of industries, including Pharmaceutical, Healthcare, Medical Device, Nicotine based products, and many others.